-
New drugs approved by NMPA in the first half of 2020
Time of Update: 2020-07-24
Text In the first half of 2020 , NMPA approved 27 new drugs, including 17 imported drugs and 10 domestically produced drugs In terms of drug types, it includes 13 drugs, 10 biological drugs, 3 Chine
-
Pfizer launched 4 Phase III clinical trials to evaluate three vaccines in development: 20 pneumonic pneumonia vaccine, RSV vaccine, 5-valent meningitis vaccine
Time of Update: 2020-07-20
, June 24, 2020 /PRNewswire Biovalley BIOON/-- Pfizer ( ) has announced the launch of four Phase III clinical trials to evaluate several vaccines in its pipeline two studies (NCT04382326 and NC
-
Roche CD20xCD3 Bispecific Antibody Mosunetuzumab Treatment Of Follicular Lymphoma, FDA Breakthrough Treatment Designation
Time of Update: 2020-07-16
Roche announced its CD20xCD3 bispecific antibody mosunetuzumab for recurrent or refractive (R/R) follicular lymphoma patients, who have previously received at least two systemic therapies, granted a b
-
Aeste announces its latest data on its new drug enfortumab vedotin in Phase 1 clinical
Time of Update: 2020-06-11
Today, Seattle Genetics and Astellas presented their latest data on the new drug at the annual meeting of ASCO studies have shown that this innovative treatment has shown promising results in the
-
Johnson and Johnson have filed a license application for stelara's complementary biologics with the FDA
Time of Update: 2020-06-10
recently, janson Pharmaceutical (http:// , owned by pharmaceutical (http:// jnd) , announced (http:// that it had submitted an application for a supplemental biological productlicense (sBLA) t
-
FDA approves listing of Pfizer biosimilar Zirabev-bvzr
Time of Update: 2020-06-09
recently, Pfizer announced that it The FDA (http:// approved the listing of its biosimilar, Zirabev-bvzr about Zirabev Zirabev is a biosimilar to the heavy anticancer drug (http:// bevacizum
-
Berry Bio Entekave generic spree application approved by FDA
Time of Update: 2020-06-08
Recently, the ubiah bio pharmaceutical (http:// (Suzhou) limited shares company (http:// of the Entikave tablets Pharmaceutical (http:// application (http:// was approved by the U.S Food M
-
Singapore holds traditional drug fair and "medicine and food" cultural relics exhibition in October
Time of Update: 2020-06-04
Business Agency July 27 - October 15-17, Singapore will host the second Traditional Medicine Fair Singapore Tourism Board, Singapore Ministry of Health and other recently jointly held in Beijing, th
-
Roche 'pinot one" FDA awards breakthrough therapy title
Time of Update: 2020-05-31
On March 3, Roche's GeneTek announced that the FDA had awarded its Esbriet (psilocybin) breakthrough therapy designation for the treatment of adult patients with unclassified intersyterirosis disease
-
China approves Roche's white cell interlocutoryin-6 monoantia to control inflammatory storms in patients with new coronavirus infection
Time of Update: 2020-05-29
China has approved the use of Roche's anti-inflammatory drug Actemra (tocilizumab), a monoantigen that targets leukade 6, in patients with coronavirus with lung complications previous studies have
-
First subcutaneous injection PD-1 declared clinical in China
Time of Update: 2020-05-29
On May 28, Pfizer submitted a clinical application for PF-06801591 injections to be accepted by CDE, the first clinically declared subcutaneous injection pD-1 monoantigen in China The results of the
-
In 2020, a batch of medical devices will be highlighted for sampling
Time of Update: 2020-03-18
At present, medical devices have become one of the most outstanding industries in China's high-tech industry, new products are emerging, product quality is constantly improving, mobile medical device
-
Pfizer's US $5.2 billion purchase of creboro ointment and its application for listing in China
Time of Update: 2020-02-11
On February 10, Pfizer's application for listing creborough ointment in China was accepted by CDE Crisaborole is a non steroidal PDE4 inhibitor obtained by Pfizer in May 2016 for us $5.2 billion to ac
-
Growth forecast of drug sales in 2020: drug K reaches the top and drug o "falls out of favor
Time of Update: 2020-01-21
Compile newborn EP vantage, a unit of evaluate, recently released its annual analysis report, listing the drugs with the most expected increase and decrease in sales in 2020 according to the consensus
-
Huabei pharmaceutical: amoxicillin capsule, metformin hydrochloride tablets have passed the consistency evaluation
Time of Update: 2020-01-16
On January 15, Huabei pharmaceutical released a notice that metformin hydrochloride tablets (0.5g) and Amoxicillin Capsules (0.5g, 0.25g) of the company passed the consistency evaluation Amoxicillin a
